Synthesis and mutagenicity of 2-aryl-substitute (o-hydroxy-, m-bromo-, o-methoxy-, o-nitro-phenyl or 4-pyridyl) benzothiazole derivatives on Salmonella typhimurium and human lymphocytes exposed in vitro

Biologia

Volumn 62, Issue 5, 2007, Pages 626-632

  Ayaz Tuylu, Berrin ^a   Zeytinoglu, Hulya Sivas ^a   Isikdag, Ilhan ^a  

^a ANADOLU UNIVERSITY   (Turkey)

Author keywords

2 aryl substitute benzothiazole; Ames test; Sister chromatid exchange

Indexed keywords

SALMONELLA TYPHIMURIUM;

EID: 50849095800     PISSN: 00063088     EISSN: 13369563     Source Type: Journal    
DOI: 10.2478/s11756-007-0122-4     Document Type: Article

References (36)

1. Akbay A., Oren, I., Temiz-Arpaci O., Aki-Sener E. & Yalcin, I. 2003. Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo(4,5-b)pyridine derivatives. Arzneimittelforschung 53(4): 266-271.
2. Ban M., Taguchi H., Katsushima T., Takahashi M., Shinoda K., Watanabe A. & Tominaga T. 1998. Novel antiallergic and anti-inflammatory agents. Part I: Synthesis and pharmacology of glycolic amide derivatives. Bioorg. Med. Chem. 6(7): 1069-1076.
3. nd ed. IRL Press, Oxford.
4. Bradshaw T.D., Stevens M.F. & WestwelL A.D. 2001. The discovery of the potent and selective antitumor agent 2-(4-amino-3-methylphenyl) benzothiazoles (DF 203) and related compounds. Curr. Med. Chem. 8(2): 203-210.
5. Bradshaw T.D. & Westwell A.D. 2004. The development of the antitumour benzothiazole prodrug, Phortress, as a clinical candidate. Curr. Med. Chem. 11(8): 1009-1021.
6. Brantley E., Stinson S., Kohlhagen G., Antony S., Sausville E. & Pommier Y. 2003. Anti-tumor 2-(4-amino-3-phenyl)-5-fluoro-benzothiazole (5F203, NSC 703786) induces single-strand breaks and DNA-protein cross-links in sensitive MCF-7 breast cancer cells. Clin. Cancer Res. 9(16): 6075S-Part 2 Suppl. S.
7. Brantley E., Patel V., Stinson S.F., Trapani V., Hose C.D., Ciolino H.P., Yeh G.C., Gutkind J.S., Sausville E.A. & Loaiza-Perez A.I. 2005. The antitumor drug candidate 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole induces NF-kappa B activity in drug-sensitive MCF-7 cells. Anti-Cancer Drugs 16(2): 137-143.
8. Cao Y.-J., Dreixler J.C., Couey J.J. & Houamed K.M. 2002. Modulation of recombinant and native neuronal SK channels by the neuroprotective drug riluzole. Eur. J. Pharmacol. 449: 47-54.
9. Chakraborti A.K., Selvam C., Kaur G. & Bhagat S. 2004. An efficient synthesis of benzothiazoles by direct condensation of carboxylic acids with 2-aminothiophenol under microwave irradiation. Synlett 5: 851-855.
10. Das J., Moquin R.V., Lin C.J., Liu J., Doweyko A.M., Defex H.F., Fang Q., Pang S.H., Pitt S., Shen D.R., Schieven G.L., Barrish J.C. & Wityak J. 2003. Discovery of 2-amino-heteroarylbenzothiazole-6-anilides as potent p56(lck) inhibitors. Bioorg. Med. Chem. Lett. 13(15): 2587-2590.
11. Hall I.H., Peaty N.J., Henry J.R., Easmon J., Heinisch G. & Purstinger G. 1999. Investigations on the mechanism of action of the novel antitumor agents 2-benzothiazolyl, 2-benzoxazolyl and 2-benzimidazolyl hydrazones derived from 2-acetylpyridine. Arch. Pharm. (Weinheim) 332(4): 115-123.
12. He X-F., Vogels C.M., Decken A. & Westcott S.A. 2004. Pyridyl benzimidazole, benzoxazole, and benzothiazole platinum complexes. Polyhedron 23(1): 155-160.
13. Hides K. & Hankovsky H.O. 1963. Benzazole compounds. Preparation of pyridylbenzazoles. Acta Chim. Acad. Hung. 43(3): 263-269.
14. Hose C.D., Hollingshead M., Sausville E.A. & Monks A. 2003. Induction of CYP1A1 in tumor cells by the antitumor agent 2-[4-amino-3-methylphenyl]-5- fluoro-benzothiazole: A potential surrogate marker for patient sensitivity. Mol. Cancer Ther. 2(12): 1265-1272.
15. Hutchinson I., Bradshaw T.D., Matthews C.S., Stevens M.F. & Westwell A.D. 2003. Antitumor benzothiazoles. Part 20: 3-cyano and 3-alkynyl-substituted 2-(4-aminophenyl)benzothiazoles as new potent and selective analogues. Bioorg. Med. Chem. Lett. 13(3): 471-474.
16. Ikegami M. & Arai T. 2002. Photoinduced intramolecular hydrogen atom transfer in 2-(2-hydroxyphenyl)benzoxazole and 2-(2-hydroxyphenyl)-benzothiazole studied by laser flash photolysis. J. Chem. Soc. Perkin Trans. 2(7): 1296-1301.
17. Isikdag I. & Ucucu U. 1990. Studies on the syhthesis of some 2-aryl and 2-heteroaryl benzothiazole derivatives and on the establishment of structure-activity relation. Tr. J. Medical Sciences 14(1): 158-168.
18. Jung M.H., Choi S-W., Park J-G., Cho K-W. & Kong J.Y. 1999. Studies of muscarinic receptor agonists: 2-(1-methyl-1,2,3,6-tetrahydropyridin-4-yl) benzoxazoles/benzothiazole. Korean J. Med. Chem. 9(2): 56-62.
19. Kodomari M., Tamaru Y. & Aoyama T. 2004. Solvent-free synthesis of 2-aryl and 2-alkylbenzothiazoles on silica gel under microwave irradiation. Synth. Commun. 34(16): 3029-3036.
20. Lefevre P., Tinwell A.H. & Ashby J. 1997. Mutajenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocols. Mutagenesis 12(1): 45-47.
21. Leong C.O., Gaskell M., Martin E.A., Heydon R.T., Farmer P.B., Bibby M.C., Cooper P.A., Double J.A., Bradshaw T.D. & Stevens M.F. 2003. Antitumour 2-(4-aminophenyl) benzothiazoles generate DNA adducts in sensitive tumour cells in vitro and in vivo. Brit. J. Cancer 88(3): 470-477.
22. Maron D.M. & Ames B.N. 1983. Revised methods for the Salmonella mutagenicity test. Mutat. Res. 113: 173-215.
23. Matsushita H., Lee S-H., Clapham B. & Janda K.D. 2004. Smart cleavage reactions: the synthesis of benzimidazoles and benzothiazoles from polymer-bound esters. Tetrahedron Lett. 45(2): 313-316.
24. Mortimer C.G., Wells G., Crochard J-P., Stone E.L., Bradshaw T.D., Stevens M.F.G. & Westwell A.D. 2006. Antitumor benzothiazoles. 26. 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon and breast cancer cell lines. J. Med. Chem. 49(1): 179-185.
25. Nagarajan S.R., De Crescenzo G.A., Getman D.P., Lu H-F., Sikorski J.A., Walker J.L., Mcdonald J.J., Houseman K.A., Kocan G.P., Kishore N., Mehta P.P., Funkes-Shippy C.L. & Blystone L. 2003. Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease. Bioorg. Med. Chem. 11(22): 4769-4777.
26. Ramirez A.D., Wong S.K-F. & Menniti F.S. 2003. Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms. Eur. J. Pharmacol. 475: 29-35.
27. Ryu C-K., Choi K.U., Shim J-Y., You H-J., Choi I.H. & Chae M.J. 2003. Synthesis and antifungal activity of 6-arylthio-/6-Arylamino-4,7- dioxobenzothiazoles. Bioorg. Med. Chem. 11(18): 4003-4008.
28. Sato G., Asakuraa S., Hakurab A., Tsutsui-Hiyoshia Y., Kobayashic N. & Tsukidatea K. 2000. Assessment of potential mutagenic activities of a novel benzothiazole MAO-A inhibitor E2011 using Salmonella typhimurium YG1029. Mut. Res. 472(1-2): 163-169.
29. Seo K.W., Park M., Kim J.G. & Kim H.J. 2000. Effects of benzothiazole on the xenobiotic enzymes and metabolism of acetaminophen. J. Appl. Toxicol. 20(6): 427-430.
30. Shi D.F., Bradshaw T.D., Wrigley S., Mccall C.J., Lelieveld P., Fichtner I. & Stevens M.F. 1996. Antitumor benzothiazoles. 3. Synthesis of 2-(4-aminophenyl) benzothiazoles and evaluation of their activities against breast cancer cell lines in vitro and in vivo. J. Med. Chem. 39(17): 3375-3384.
31. Turan-Zitouni G., Demirayak S., Ozdemir A., Kaplancikli Z.A. & Yildiz M.T. 2003. Synthesis of some 2-[(benzazole-2-yl)thioacetylamino]thiazole derivatives and their antimicrobial activity and toxicity. Eur. J. Med. Chem. 39(3): 267-272.
32. Tuylu Ayaz B. & Zeytinoglu H. 2004. Genotoxicity of some benzothiozole derivatives on human lymhocytes exposed in vitro. Toxicol. Appl. Pharmacol. 197(3): 501.
33. Ulrich H. 2002. Product class 18: Benzothiazoles and related compound. Sciences of Synthesis 11: 835-912.
34. Wells G., Bradshaw T.D., Diana P., Seaton A., Shi D.F., Westwell A.D. & Stevens M.F. 2000. Antitumour benzothiazoles. Part 10. The synthesis and antitumour activity of benzothiazole substituted quinol derivatives. Bioorg. Med. Chem. Lett. 10(5): 513-515.
35. Westwell A.D. 2004. The therapeutic potential of aryl hydrocarbon receptor (AhR) agonists in anticancer drug development. Drugs of the Future 29(5): 479-491.
36. Zeytinoglu H., Meric A., Tuylu B. & Ergene E. 2006. Synthesis and genotoxic activities of five 2-aryl-substitutedbenzothiazole derivatives. Rev. Chim. 57(12): 1247-1252.